Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Aug 6, 2023
Date Accepted: Sep 6, 2024
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Engine of Innovation in Hospital Pharmacy: Applications and Reflections of ChatGPT
ABSTRACT
Hospital pharmacy is a crucial domain ensuring medical care quality and safety. However, it confronts challenges in drug information retrieval, therapy guidance, and interaction management. ChatGPT is a powerful artificial intelligence language model that can generate natural language texts and answer various questions. In this article, we explored the applications and reflections of ChatGPT in hospital pharmacy, where it can potentially enhance the quality and efficiency of pharmaceutical care. We also explored ChatGPT's prospects in hospital pharmacy and discussed its working principle, diverse applications, and practical cases in daily operations and scientific research. Meanwhile, the challenges and limitations of ChatGPT, such as data privacy, ethical issues, bias and discrimination, and human oversight were discussed. ChatGPT is a promising tool for hospital pharmacy, but it requires careful evaluation and validation before it can be integrated into clinical practice. We also provided some suggestions for future research and development of ChatGPT in hospital pharmacy.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.